Novartis AG
Lipid-based ophthalmic emulsion
Last updated:
Abstract:
The present invention is directed to a lipid-based ophthalmic emulsion. The emulsion has an increased amount of a mucoadhesive galactomannan polymer that promotes a long-lasting protection against desiccation and moisture retention.
Status:
Grant
Type:
Utility
Filling date:
21 Feb 2019
Issue date:
23 Feb 2021